ahlam1399
02-18-2016, 04:30 PM
Zafgen?s obesity drug succeeds in mid-stage trial
(Reuters) - Drug developer Zafgen Inc said on Thursday that its drug to treat obesity in diabetic patients met the main goal of reducing body weight.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4dadd996/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=PMDQMGlSsEc:FOLDjkdradQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=PMDQMGlSsEc:FOLDjkdradQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=PMDQMGlSsEc:FOLDjkdradQ:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=PMDQMGlSsEc:FOLDjkdradQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=PMDQMGlSsEc:FOLDjkdradQ:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/PMDQMGlSsEc
(Reuters) - Drug developer Zafgen Inc said on Thursday that its drug to treat obesity in diabetic patients met the main goal of reducing body weight.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4dadd996/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=PMDQMGlSsEc:FOLDjkdradQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=PMDQMGlSsEc:FOLDjkdradQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=PMDQMGlSsEc:FOLDjkdradQ:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=PMDQMGlSsEc:FOLDjkdradQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=PMDQMGlSsEc:FOLDjkdradQ:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/PMDQMGlSsEc